No Prescription |
 |
 | ||
|
CLAMYCIN Klarcid |
|
| ||
No Prescription » Prescription Drugs 4 » CLAMYCIN Klarcid Clarithromycin is used to treat a wide variety of bacterial infections. This medication can also be used in combination with anti-ulcer medications to treat certain types of stomach ulcers. It may also be used to prevent certain bacterial infections. Clarithromycin is a macrolide antibiotic that works by stopping the growth of bacteria.This antibiotic treats only bacterial infections. It will not work for viral infections (e.g. common cold flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.How to use Clarithromycin OralTake this medication by mouth with or without food usually twice daily or as directed by your doctor. If stomach upset occurs you may take it with food or milk.Antibiotics work best when the amount of medicine in your body is kept at a constant level. Therefore take this drug at evenly spaced intervals at the same time(s) each day.The dosage and duration of therapy is based on your medical condition and response to therapy.If you are using this medication to treat an infection continue to take this medication until the full-prescribed amount is finished even if symptoms disappear after a few days. Stopping the medication too early may allow bacteria to continue to grow which may result in a relapse of the infection. Inform your doctor if your condition persists or worsens.If you are taking this medication for the prevention of certain bacterial infections take it exactly as directed by your doctor. Do not stop taking the medication without your doctor's approval. Buy CLAMYCIN Klarcid and other Prescription Drugs 4 products online at Medstore. 676
About CLAMYCIN Klarcid: Product Type: Prescription Drugs 4 CLAMYCIN ( Klarcid Biaxin Generic Clarithromycin ) CLAMYCIN (Klarcid Biaxin Generic Clarithromycin) Klarcid Biaxin Generic Clarithromycin 250mg Tabs 20 (5 x 4) Klarcid Biaxin Generic Clarithromycin CLAMYCIN
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
